Introduction
The nuclear factor-kB (NF-kB) family of transcription factors plays a pivotal role in inflammation, proliferation, and prevention of apoptosis (Li and Verma, 2002; Ben-Neriah and Schmitz, 2004) . It has been reported that stimulation by cytokines, such as tumor necrosis factor (TNF)-a or IL-1b, requires the canonical inhibitor of NF-kB (IkB) kinase (IKK) complex containing NF-kB essential modulator (NEMO, also called IKKg) for NF-kB activation (Yamaoka et al., 1998; Makris et al., 2002; Ben-Neriah and Schmitz, 2004) . The canonical NF-kB signaling pathway involves IKK2 (also called IKKb) and leads to nuclear translocation of RelA-containing NF-kB dimers (Ben-Neriah and Schmitz, 2004) . In contrast, B-cell activating factor receptor (BAFF-R), CD40, or TNF-like weak inducer of apoptosis (TWEAK) were reported to activate the noncanonical NF-kB signaling pathway, which did not necessarily require NEMO for NF-kB activation (Claudio et al., 2002; Coope et al., 2002; Kayagaki et al., 2002; Saitoh et al., 2003) . The noncanonical NF-kB signaling pathway involves IKK1 (also called IKKa) and leads to the phosphorylation and processing of p100, resulting in nuclear translocation of RelB-containing NF-kB dimers (Solan et al., 2002; Derudder et al., 2003; Ben-Neriah and Schmitz, 2004 ).
Hodgkin's lymphoma (HL) is characterized by a low frequency of malignant Hodgkin and Reed-Sternberg (H-RS) cells in a reactive background of non-neoplastic cells. (Horie et al., 2003; Thomas et al., 2004) . The peculiar activated phenotype of H-RS cells and their pattern of cytokine secretion, which contribute to the pathological appearance and clinical manifestations of the disease, are believed to be consequences of constitutive NF-kB activation (Skinnider and Mak, 2002) . Inhibition of constitutive NF-kB led to decreased proliferation, enhanced apoptotic response, and strongly impaired tumor growth in immuno-deficient mice (Bargou et al., 1997; Hinz et al., 2002) . These observations suggested an important role for NF-kB in the pathogenesis of HL. HL is often associated with Epstein-Barr virus (EBV), and several research groups including ours have recently demonstrated that the EBV-encoded latent membrane protein-1 activates the canonical and noncanonical NF-kB signaling pathways (Atkinson et al., 2003; Eliopoulos et al., 2003; Saito et al., 2003) . Of note, constitutive IKK activation was observed both EBV-positive and -negative HL cell lines (Krappmann et al., 1999; Mathas et al., 2003) .
CD30 is one of the TNF receptor (TNFR) family members implicated in lymphoid cell maturation as well as in the development of hematologic malignancies including HL, anaplastic large-cell lymphoma (ALCL), and immunoblastic lymphoma, but the biological consequences of CD30 expression in the pathogenesis of these diseases have not been well understood (Opat and Gaston, 2000; Schneider and Hu¨binger, 2002; Horie et al., 2003) . We previously showed that overexpression of CD30 led to recruitment and self-aggregation of TNF receptor-associated factor (TRAF)2 and TRAF5, resulting in constitutive NF-kB activation, independently of the CD30 ligand (Horie et al., 2002) . A high level of CD30 expression is a phenotype shared with ALCL (Stein et al., 2000) . However, we have quite recently demonstrated that constitutive NF-kB activation is not observed in ALCL cells because the nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) chimeric protein, which is characteristic of most systemic/nodal ALCL, abrogates CD30-driven NF-kB activation (Horie et al., 2004) .
In this study, we report enhanced proteasomedependent processing of p100 to p52 in EBV-negative H-RS cell lines. We also show that overexpression of CD30 results in transformation of rat fibroblasts as well as constitutive NF-kB activation similar to that in H-RS cells, suggesting contribution of deregulated CD30 signaling to malignant cell transformation of H-RS cells.
Results

Aberrant expression of NF-kB p52 and RelB in H-RS cells
It was reported that H-RS cell lines as well as primary tumor cells from Hodgkin disease patients showed constitutive NF-kB DNA-binding activity comprised of p50 and RelA (Bargou et al., 1997) . We analysed the DNA-binding NF-kB components in Jurkat, human Tcell leukemia virus type I (HTLV-I)-infected MT-2 and EBV-negative H-RS cell lines by supershift assay (Figure 1a) . The poor NF-kB DNA-binding activity of Jurkat cells contained mainly p50 and c-Rel, while all the examined components were included in the strong NF-kB-DNA-binding activity of MT-2 cells. In the H-RS cells, the DNA-binding NF-kB components were composed not only of p50 and RelA but also of RelB and p52 in the H-RS cells. Indeed, an immunoblot study revealed aberrant expression of p100 as well as its processed form p52 in H-RS cells (Figure 1b) . Parallel immunoblotting of 293 T cells expressing p100 and/or NF-kB-inducing kinase (NIK), which is known to trigger IKK1 activation and subsequent phosphorylation-dependent p100 processing to p52, served as positive and negative controls (Figure 1b) . Although expression of p100 and p52 in L540 cells was relatively weak among H-RS cells, L540 cells expressed more p52 than Jurkat or vector-transfected 293 T cells, in which p52 was undetectable. To know whether the processing of NF-kB2 p100 to p52 is proteasome-dependent in H-RS cells, we used a proteasome inhibitor MG132 and analysed H-RS cells (HDLM-2, L540, and L428) for p100 and p52 expression by immunoblotting ( Figure 1c) . As positive and negative controls, we used MT-2 and Jurkat cells, respectively. MT-2 cells were established in vitro and express the HTLV-I Tax protein, which is known to induce canonical NF-kB activation and the processing of p100 through its physical binding to p100 (Xiao et al., 2001; Hironaka et al., 2004) . As shown in Figure 1c , MG132 treatment induced transient p100 accumulation in L540 and L428 cells and reduced p52 expression in MT-2, HDLM-2, L428, and L540 cells. The effect of MG132 on p100 and p52 levels was not so striking in tumor cells when compared to cells stimulated with cytokines (Coope et al., 2002; Dejardin et al., 2002) , because of the presence of p52 prior to the MG132 treatment. These results indicate that the generation of p52 in H-RS cells involves proteasomedependent processing of NF-kB2 p100.
Protein synthesis inhibition impairs IKK activity in H-RS cells in correlation to the p100 status
To investigate the mechanism of IKK activation in H-RS cells, we assessed effects of a protein synthesis inhibitor cycloheximide (CHX) on IKK activity in H-RS cells, because it was previously shown that prior treatment with CHX inhibited signal-induced processing of p100, but not the canonical NF-kB activation (Coope et al., 2002; Mu¨ller and Siebenlist, 2003) . Whole-cell extracts were prepared from MT-2 and H-RS cells treated with or without CHX for 4 h, and then IKK1-associated kinase activity was determined by in vitro kinase assay (Figure 2 ). Addition of CHX led to a marked reduction of IKK activity in L540 cells, while HDLM-2 and L428 cells showed moderate reduction of IKK activity in the presence of CHX. CHX had no appreciable effect on IKK activity in MT-2 cells, whereas Tax activates IKK in a NEMO-dependent manner. Parallel immunoblotting revealed equivalent amounts of IKK1 in the immunoprecipitates from these cells. Thus, the relative contribution of the CHXsensitive pathway to IKK activation was varied depending on the H-RS cell lines, and the levels of p100 expression in these cells (Figure 1b ) appeared to be correlated with their CHX-resistant IKK activity.
Transforming property of CD30
We recently reported that overexpression of CD30 in 293 cells induced self-association of CD30, leading to persistent NF-kB activation independently of the CD30 ligand (Horie et al., 2002) . To examine if overexpression of CD30 results in cell transformation in an NF-kBdependent manner, CD30 was expressed in a subline of Rat-1, B5, that carries integrated form of pIgk2bsrH (Yamaoka et al., 1998) and becomes resistant to blasticidin S under constitutively elevated NF-kB activity (Chinanonwait et al., 2002) . B5 cells were infected with retrovirus capable of expressing human CD30 and cultured in the presence of puromycin for a couple of days to establish a pool of infected cells. At this stage, pooled cells did not show apparently elevated NF-kB-specific DNA-binding activity or CD30 expression comparable to that seen in H-RS cell lines (data not shown). Retrovirus-transduced B5 cells were then subjected to selection with blasticidine S, which resulted in survival of CD30-transduced B5 (B5-CD30) cells. This was not caused by a nonspecific retroviral mutagenesis, because there was absolutely no survival with vector-transduced B5 (B5-vector 1) cells after blasticidin S selection. Therefore, we used in the following experiments a puromycin-resistant pool of (Table 1) . B5-vector 1 cells did not form significant number of colonies larger than 60 mm in diameter, while B5-CD30 cell clones efficiently formed large colonies in soft agar ( Figure 4 and Table 1 ). These data indicate that overexpression of CD30 induces transformation of rat fibroblasts. This transformed phenotype was completely reversed by retroviral expression of a super-repressor form of IkBa (SR-IkBa) ( Figure 4 and Table 1 ), indicating that this transformation depends on the constitutive NF-kB activity induced by CD30. As expected, the high NF-kB DNA-binding activity was lost in SR-IkBa-transduced B5-CD30 cells (Figure 3a) , while the expression levels of CD30 on SR-IkBatransduced B5-CD30 cells remained similar to those on B5-CD30 cells (Figure 3b ). In addition, p100 and p52 virtually disappeared in SR-IkBa-transduced B5-CD30 cells, presumably as a consequence of loss of NF-kBdependent p100 production. Supershift analyses revealed that NF-kB DNA-binding components induced in B5-CD30 clone 6 cells included RelB (Figure 5a ). We were unable to examine the presence of p52 in the NF-kB DNA-binding components, because antibody capable of surpershifting rat p52 was not available. We next examined effects of MG132 on the p100 and p52 levels in B5-CD30 clone 6 cells by immunoblotting. B5-CD30 clone 6 cells aberrantly expressed p100 as well as p52 compared with control cells. Addition of MG132 resulted in a marked decrease in p52, while the level of p100 remained high (Figure 5b ). We further assessed if CHX treatment affects IKK activity in B5-CD30 clone 6 cells. Cells were treated with or without CHX for 4 h, and then IKK1-associated kinase activity was determined by in vitro kinase assay (Figure 5c ). Addition of CHX to B5-CD30 clone 6 cells led to a remarkable reduction of IKK activity as observed for L540 H-RS cells treated with CHX (Figure 2 ). NF-kB DNA-binding activity in B5-CD30 clone 6 cells was not enhanced further in response to stimulation for 8 h by the CD30's ligand CD153 expressed on fixed mouse cells (Figure 5e and f), while this stimulation induced ligand-dependent NF-kB activation in B5 cells expressing CD30 at lower levels (B5-CD30 pool) (Figure 5d and f) . Similar results were obtained with other B5-CD30 cell clones (data not shown). NF-kB DNA-binding components induced by CD153 stimulation in B5-CD30 pool cells included relatively more RelA and less RelB compared to those in B5-CD30 clone 6 cells (Figure 5g ), due to the initial canonical NF-kB activation and delayed triggering of the noncanonical pathway. Another piece of evidence supporting the noncanonical NF-kB activation by CD30 is that transient CD30 expression activated an NF-kB-dependent promoter in an NEMO-deficient subline of Rat-1, 5R, in which latent membrane protein 1 of EBV, but not TNFa, activated NF-kB (Saito et al., 2003) (Figure 6 ).
Discussion
High levels of CD30 expression, constitutive NF-kB activation, and cell transformation Constitutive NF-kB activity in H-RS cells was reported to contribute to the aberrant cytokine gene expression and neoplastic features of H-RS cells (Hinz et al., 2002; Skinnider and Mak, 2002) . Enhanced expression of many NF-kB target genes including chemokines, cytokines, and apoptosis regulators was shown in H-RS cells (Skinnider and Mak, 2002; Ku¨ppers et al., 2003) and abrogation of NF-kB activity induced apoptosis in H-RS (HDLM-2) cells (Hinz et al., 2002) . These observations suggested an important role for NF-kB in the pathogenesis of HL. As for mechanistic explanations, Krappmann et al. (1999) revealed constitutive IKK activity in the HDLM-2, L1236, and KMH-2 cell lines, while mutations in the IkBa or IkBe genes as well as amplification of the NF-kB/REL locus were also reported (Cabannes et al., 1999; Joos et al., 2002; Martı´n-Subero et al., 2002; Barth et al., 2003; Emmerich et al., 2003) . In fact, among the three EBV-negative cell lines used in this study, L428 expresses inactive IkBa and IkBe, while the other two express intact IkB proteins. Loss of functional IkBs may facilitate translocation of RelA-containing NF-kB complexes, but the processing of p100 caused by constitutively elevated IKK1-associated kinase activity in H-RS cells including L428 (Figures 1 and 2 ) cannot be explained solely by inactivation of the IkB proteins. While elevated expression of mRNA for p100 in H-RS cells was previously reported (Hinz et al., 2002) , this report has demonstrated aberrant p52 expression in H-RS cells. The elevated IKK1-associated kinase activity and processing of p100 in H-RS cells (Figures 1 and 2) are compatible with the recently highlighted noncanonical NF-kB activation, which is characterized by NEMO-independent We previously demonstrated that overexpressed CD30 triggered self-multimerization and recruitment of TRAF proteins, leading to ligand-independent NFkB activation (Horie et al., 2002) . The present report demonstrates for the first time that overexpression of CD30 in rat fibroblasts at levels similar to those in H-RS cells leads to ligand-independent transformation accompanied by CHX-sensitive constitutive IKK activation and induction of RelB-containing NF-kB complexes, the features that can also be seen in H-RS cells (Table 1, Figures 3, 4 and 5). These observations suggest that CD30 is a likely candidate that participates in the constitutive NF-kB activation and development of the oncogenic phenotype found in EBV-negative H-RS cells. Since two other TNF receptor family proteins CD40 and RANK are also reported to be expressed in H-RS cells (Carbone et al., 1995; Annunziata et al., 2000; Fiumara et al., 2001; Ku¨ppers et al., 2003) and implicated in the processing of p100 (Coope et al., 2002; Novack et al., 2003) , it would be intriguing to examine possible contribution of these molecules to the NF-kB activity in H-RS cells. Several lines of evidence suggest that CD30 supports survival of H-RS cells in multiple ways. CD30 stimulation induced upregulation of the Cells were cultured in 0.33% agarose containing regular medium for 2 weeks. Colonies larger than 60 mm were counted microscopically and the average size of colonies is indicated CD30 triggers noncanonical NF-jB activation M Nonaka et al How does the processing of p100 contribute to constitutive NF-kB activity?
The processing of p100 to p52 is often associated with constitutive NF-kB activity in human malignancies and cytokine-induced long-lasting NF-kB activation (Dejardin et al., 1999; Cogswell et al., 2000; Ben-Neriah and Schmitz, 2004; Chen and Greene 2004; Hironaka et al., 2004) , suggesting that p100 processing contributes to the temporal control of NF-kB activity. In mammalian cells, p100 was shown to have powerful IkB activity on RelA and RelB (Solan et al., 2002) . Derudder et al. (2003) demonstrated that p100 interacted with and inhibited DNA binding of RelB-containing complexes quickly after TNFa stimulation, while lymphotoxin b signaling involved p100 processing and did not induce such inhibition by p100 (Derudder et al., 2003) . The expression of p100 is induced upon NF-kB activation, while its processing is usually regulated tightly in a NIK-, IKK1-and proteasome-dependent manner. This helps to ensure the rapid downregulation of NF-kB activity following NF-kB activation by TNFa, IL1b, or LPS. Thus, abrogation of this inducible autoregulated inhibitory pathway is likely to be required for persistent NF-kB activation found in tumor cells. Regarding regulation of IKK activity leading to p100 processing, Liao et al. (2004) recently showed that induction of p100 processing by extracellular signals involves degradation of TRAF3 accompanied by enhanced expression of NIK, which serves as a docking molecule recruiting IKKa to p100. Annunziata et al. (2000) reported that CD40-induced NF-kB activation was mediated by proteolysis of TRAF3 in H-RS (KM-H2) cells. These reports suggest that TRAF3 may be involved in constitutive NF-kB activity in H-RS cells. Obviously, further efforts will be required to elucidate roles of TRAF3 and NIK in the regulation of IKK and p100 processing in H-RS cells. In summary, this study has demonstrated that overexpression of CD30 induces ligand-independent cell transformation and triggers the noncanonical NF-kB signaling, which is also observed in H-RS cells. Our results suggest that overexpression of CD30 may contribute to the neoplastic phenotype of HL.
Materials and methods
Cells and viruses
HDLM-2, L428, and L540 cell lines were purchased from the German Collection of Micro-organisms and Cell Cultures (Braunschweig, Germany). MT-2 is a human T cell line transformed in vitro with HTLV-I (Sugamura et al., 1984) . These cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum and antibiotics. Rat-1, 5R, B5, SV-T2, 293T, and PLAT-E packaging cells were previously described and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics. (Yamaoka et al., 1998; Morita et al., 2000; Takahashi et al., 2001; Chinanonwait et al., 2002) . For production of retroviruses, PLAT-E cells were transfected using FuGENE 6 (Roche Diagnostics Co., IN, USA) according to the manufacturer's instructions. Culture supernatants of PLAT-E cells were collected 48 h after transfection. Approximately 3 Â 10 5 B5 cells were infected with retrovirus capable of expressing human CD30 or empty vector (vector 1). Cells were selected in the presence of 2 mg/ml of puromycin and pools of infected cells (B5-vector 1 or B5-CD30-pool) were established. Infected cells were then subjected to selection with 5 mg/ml of Blasticidin S. Individual 11 cell clones were isolated (B5-CD30 clones) and used for further experiments. B5-vector 1 and B5-CD30 clone cells were infected with retrovirus capable of expressing a super-repressor form of IkBa (SRIkBa) or empty vector (vector 2) with a similar procedure. Pools of SR-IkBa-transduced B5-vector 1 or B5-CD30 cells (B5-vector 1-SR-IkBa or B5-CD30-SR-IkBa) were established following selection of infected cells with 400 mg/ml of Zeocin. SV-T2-vector and SV-T2-CD153 cells were established by infection of SV-T2 cells with retrovirus prepared with pMRXpuro and pMRX-CD153-puro, respectively. SV-T2-vector and SV-T2-CD153 cells were treated with a buffer (20 mM HEPES (pH7.4), 100 mM NaCl, 10 mM EDTA, 0.5% BSA) for 20 min at 41C and 10 min at 371C, dislodged by vigorous pipetting, fixed in PBS containing 4% paraformaldehyde (PFA) for 15 min at room temperature, and then washed three times by PBS before being used for stimulation. PFA-fixed SV-T2-vector or SV-T2-CD153 cells were added to the culture of B5-vector1, B5-CD30-pool, or B5-CD30 clone cells, and then the cells were lysed after 8 h of incubation. 293 T cells were transfected by the calcium phosphate precipitation method.
Reagents
Anti-p52 serum (06-413) used for supershift assay was purchased from Upstate Biotechnology, Inc., NY, USA. Anti-p50 recognizing mouse p50, anti-RelA, and anti-RelB sera were kindly provided by Drs N Rice and A Israe¨l (Institut Pasteur de Paris, France). Anti-p50 (H-119), anti-c-Rel (N), anti-IKK1 (H-744), anti-IkBa (C-21), anti-actin (C-2), anti-NIK (H-248), and anti-p52 antibodies (C-5) were purchased from Santa Cruz Biotechnology, CA, USA. Anti-IKK1 antibody (IMG-136) was purchased from IMGENEX (CA, USA). FITC-conjugated anti-CD30 antibody and mouse IgG1 used for Flow Cytometric analysis were purchased from DAKO (Glostrup, Denmark). FITC-conjugated anti-mouse IgG for Flow Cytometric analysis was purchased from American Qualex manufactures (CA, USA). Anti-IKK1 monoclonal (556532) and anti-CD153 antibodies were purchased from Becton Dickinson Pharmingen (CA, USA). Puromycin and Blasticidin S were purchased from Funakoshi (Tokyo, Japan) and Zeocin were from Invitrogen (CA, USA). CHX and paraformaldehyde (PFA) were purchased from Wako (Osaka, Japan). All the other reagents, including MG132, were purchased from Sigma (MO, USA) unless otherwise noted. Cells were treated with 20 mM of MG132 or 50 mg/ml of CHX, if necessary.
Plasmids
A ScaI/BglII DNA fragment, containing the cytomegalovirus early enhancer-promoter, U3-deleated murine leukemia viruslong terminal repeat and packaging signal, was excised from pRxhCD25iN (Hanada et al., 1996) and subcloned into the same enzymatic site of pMX-puro (Kawakami et al., 1997) , generating pMRX-puro. pCn, pCn-100 (Yamaoka et al., 1996) , pRK-5 vector, and pRK-NIK (Hsu et al., 1996) (kind gifts of Dr D Goeddel, Amgen, CA, USA) were described previously. An MluI/NotI DNA fragment containing the entire coding region of human CD30 was excised from pME-CD30 (Horie et al., 2002) and subcloned into the BglII/NotI site of pMRX-puro, generating pMRX-CD30-puro. A SalI DNA fragment containing the Zeocin-resistance gene derived from pZeoSV (Invitrogen, CA, USA) and an internal ribosome entry site (IRES) sequence was subcloned into the SalI sites of pMX-puro, generating pMX-IRES-Zeocin. An EcoRI fragment containing the coding sequence of IkBa with S32A S36A mutations was excised from pRc-CMV-IkBa (Whiteside et al., 1995) and subcloned into the EcoRI site of pMX-IRESZeocin, generating pMX-SR-IkBa-IRES-Zeocin. A cDNA of human CD153 was amplified by PCR using cDNAs prepared from MT-2 cells (Sugamura et al., 1984) as a template. A BamHI/NotI fragment containing the entire coding region of human CD153 was subcloned between the BamHI and NotI sites of pMRX-puro, generating pMRX-CD153-puro. Full construction details are available upon request.
Flow cytometric analysis
For detection of cell surface CD30, approximately 5 Â 10 5 cells were stained with FITC-conjugated anti-CD30 antibody or FITC-conjugated mouse IgG1 at a concentration of 5 mg/ml for 30 min on ice. For detection of cell surface CD153, SV-T2 cells were stained with anti-CD153 monoclonal antibody or mouse IgG1 followed by a second staining with FITCconjugated anti-mouse IgG. After staining, cells were washed, resuspended, and subjected to FACScalibur analysis. The data were analysed with the CellQuest program.
Tumorigenicity assay
Anchorage-independent cell growth was examined essentially as described previously (Yamaoka et al., 1996) .
Preparation of cell extracts
For preparation of whole-cell extracts, cells were suspended in RIPA buffer (20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10% glycerol, 1% Nonidet P-40, 0.5% deoxycholate, and 0.1% SDS), supplemented with 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml leupeptin and 1 mg/ml aprotinin. Extracts were cleared by centrifugation. Cytoplasmic and nuclear extracts were prepared as described previously (Yamaoka et al., 1998) .
Western blot analysis
Whole-cell extracts or cytoplasmic extracts were fractionated on 8-12% SDS-polyacrylamide gels and transferred onto Immobilon membranes (Millipore, MA, USA). Blots were revealed with an enhanced chemiluminescence detection system (ECL, Perkin Elmer, MA, USA). All the experiments were repeated at least twice. Densitometry was performed using ATTO Densitograph (Bioscience & Biotechnology ATTO, Tokyo, Japan). The relative band intensity of p100 or p52 was normalized to that of actin.
EMSA
Nuclear extracts (5 mg) were incubated for 30 min at room temperature in binding buffer (10 mM HEPES (pH 7.8), 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 2.5% glycerol, 1 mg of poly (d (I-C))) with 0.5 ng of 32 P-labeled kB probe derived from the H-2K b promoter (Yamaoka et al., 1998) or 32 Plabeled Oct-1 probe (Mori et al., 2000) . For supershift assays, nuclear extracts were incubated with specific antibodies for 30 min on ice before incubation with the labeled probe. Samples were run on a polyacrylamide gel containing 2.5% glycerol in 0.5 Â TBE. All the experiments were performed at least twice.
Immunoprecipitation and kinase assay
Cytoplasmic extracts were subjected to immunoprecipitation with anti-IKK1 antibody in TNT buffer (20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 1% Triton X-100, 0.5 mM PMSF, 100 mM Na 3 VO 4 , 20mM b-glycerophosphate, 1 mg/ml leupeptin, and 1 mg/ml aprotinin). Immunoprecipitates were collected on protein G-sepharose beads (Pierce, IL, USA), which were then washed three times with TNT buffer and three times with kinase reaction buffer (20 mM HEPES (pH 7.5), 10 mM MgCl 2 , 50 mM NaCl, 100 mM Na 3 VO 4 , 20 mM b-glycerophosphate, 2 mM DTT, and 20 mM ATP). The immunoprecipitates were used in in vitro kinase assay and immunoblotting for detection of immunoprecipitated IKK1. Kinase reaction was performed for 30 min at 301C using 5 mCi of [g-32 P]ATP and glutathione-S-transferase (GST)-IkBa (amino acids 1-72) as substrate (Yamaoka et al., 1998) . The reaction products were separated on 12% SDSpolyacrylamide gels and revealed by autoradiography.
Reporter gene assays
IgkCona-luc (Munoz et al., 1994) was used to determine NFkB-dependent transcriptional activation in Rat-1 and 5R cells. Cells were transfected with pME or pME-CD30 (Horie et al., 2004) along with IgkCona-luc and pEF1-LacZ (Yamaoka et al., 1998) by a calcium phosphate co-precipitation method. Assays for luciferase and b-galactosidase were performed 36 h after transfection in standard methods. Luciferase activity was normalized on the basis of b-galactosidase activity. Each experiments was repeated at least three times, and the results are expressed as a mean with s.d.
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